Financial expert analyzes DAX development and fall in Bayer & Morphosys share price
According to a report from www.faz.net, the day after the massive 18 percent fall in Bayer shares, the Dax showed a slight increase of 0.2 percent. The market is entering a phase of restraint as investors tend to wait after a long winning streak. The minutes of the most recent interest rate meeting of the US Federal Reserve also play an important role. Morphosys shares plunge 26 percent after the biotech company failed to show statistical significance in a key study. The financial investor Permira has sold another 13 million shares in the software provider Teamviewer, causing the share price to fall. In contrast, the…

Financial expert analyzes DAX development and fall in Bayer & Morphosys share price
According to a report by www.faz.net,
The day after Bayer's share price fell massively by 18 percent, the Dax showed a slight increase of 0.2 percent. The market is entering a phase of restraint as investors tend to wait after a long winning streak. The minutes of the most recent interest rate meeting of the US Federal Reserve also play an important role.
Morphosys shares plunge 26 percent after the biotech company failed to show statistical significance in a key study. The financial investor Permira has sold another 13 million shares in the software provider Teamviewer, causing the share price to fall.
In contrast, the share prices of the defense company and automotive supplier Rheinmetall are rising due to new targets for the period up to 2026.
Evonik's majority shareholder RAG-Stiftung plans to issue convertible bonds worth 500 million euros, which can be exchanged for shares in the specialty chemicals group. At the same time, outstanding bonds are to be bought back in the same amount, which will lead to a fall in the share price.
Overall, there are clear influences in various areas of the market that lead to price changes and general reluctance. The uncertainty and caution of investors is reflected in the development of share prices.
The effects on the market are complex. The fall in Bayer's share price shows that individual negative events can influence the entire market. This can lead to general uncertainty and reluctance among investors, which affects the development of the entire market. The falling share prices of Morphosys and Teamviewer show that industry-specific events can also have a strong impact. Rheinmetall's positive targets and Evonik's planned issue of convertible bonds, on the other hand, have a positive impact on selected companies, but also show how specific corporate decisions can influence the market. Overall, the development of the market depends on a variety of factors that need to be analyzed and taken into account.
Read the source article at www.faz.net